These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37034205)

  • 1. Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer.
    Wei Y; Niu Z; Hou X; Liu M; Wang Y; Zhou Y; Wang C; Ma Q; Zhu Y; Gao X; Li P; Gao S; Zhan S; Yang Z; Tai Y; Shao Q; Ge J; Hua J; Gao L; Sun Q; Jiang H; Huang H
    Am J Cancer Res; 2023; 13(3):1091-1102. PubMed ID: 37034205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer.
    Zhang X; Niu Z; Qin H; Fan J; Wang M; Zhang B; Zheng Y; Gao L; Chen Z; Tai Y; Yang M; Huang H; Sun Q
    Front Oncol; 2019; 9():895. PubMed ID: 31681557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-Based Analysis of Cell-in-Cell Structures in Esophageal Squamous Cell Carcinoma.
    Wang Y; Niu Z; Zhou L; Zhou Y; Ma Q; Zhu Y; Liu M; Shi Y; Tai Y; Shao Q; Ge J; Hua J; Gao L; Huang H; Jiang H; Sun Q
    Front Oncol; 2021; 11():670051. PubMed ID: 34178655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of the phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in non-small cell lung carcinoma.
    Jiang AG; Yu H; Huang JA
    Oncol Lett; 2014 Aug; 8(2):601-607. PubMed ID: 25013474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Survival Prognostic Model for Non-small Cell Lung Cancer.
    Zhang YH; Lu Y; Lu H; Zhou YM
    Front Oncol; 2020; 10():362. PubMed ID: 32266143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
    Hu M; Xu Q; Yang S; Han S; Zhu Y; Lin Q; Sun X; Liu H; Xu Y
    Ann Transl Med; 2020 Oct; 8(20):1310. PubMed ID: 33209890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with 
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
    Ren H; Xu W; You J; Song X; Huang H; Zhao N; Ren X; Zhang X
    Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):192-9. PubMed ID: 27118646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer.
    Ran H; Ma J; Cai L; Zhou H; Yuan Z; Chen Y; Chang W; Huang Y; Xiao Y
    BMC Cancer; 2022 Jan; 22(1):93. PubMed ID: 35062903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer.
    Li Z; Zhou B; Zhu X; Yang F; Jin K; Dai J; Zhu Y; Song X; Jiang G
    Front Immunol; 2023; 14():1123840. PubMed ID: 36969247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
    Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study.
    Wei S; Shao J; Wang J; Wang G
    Ann Transl Med; 2022 Apr; 10(8):457. PubMed ID: 35571436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research for mediastinal lymph node desection style of stage Ib upper lobe non-small cell lung cancer].
    Wang W; Mao F; Shen-Tu Y; Mei Y
    Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):584-90. PubMed ID: 24229624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
    Zhang M; Wen F; Zhao K
    J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2007 Oct; 110(7):1532-41. PubMed ID: 17702091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.